Kesar Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.45 Cr
as on 21-06-2024
- Paid Up Capital ₹ 3.45 Cr
as on 21-06-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.52 Cr
as on 21-06-2024
- Satisfied Charges ₹ 7.65 Cr
as on 21-06-2024
- Revenue 9.24%
(FY 2022)
- Profit 116.81%
(FY 2022)
- Ebitda 434.53%
(FY 2022)
- Net Worth 140.68%
(FY 2022)
- Total Assets 19.74%
(FY 2022)
About Kesar Pharma
The Corporate was formerly known as Kesar Swasthya Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.45 Cr and a paid-up capital of Rs 3.45 Cr.
The company currently has active open charges totaling ₹11.52 Cr. The company has closed loans amounting to ₹7.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prakash Patel, Kalpesh Shah, and Parth Parikh serve as directors at the Company.
- CIN/LLPIN
U24239GJ2011PTC067520
- Company No.
067520
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kesar Pharma Private Limited offer?
Kesar Pharma Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Anti Infective Drugs & Medicines, Antiviral Drugs, Malaria Medicine, Antibiotic Tablets, Capsule & Syrup, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Kesar Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Patel  | Director | 18-Oct-2011 | Current |
| Kalpesh Shah | Director | 01-May-2014 | Current |
| Parth Parikh | Director | 06-Sep-2019 | Current |
Financial Performance of Kesar Pharma.
Kesar Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.24% increase. The company also saw a substantial improvement in profitability, with a 116.81% increase in profit. The company's net worth Soared by an impressive increase of 140.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kesar Pharma?
In 2021, Kesar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kesar Finechem Private LimitedActive 3 years 1 monthPrakash Patel, Kalpesh Shah and 1 more are mutual person
- Hapax Pharma Private LimitedActive 10 years 3 months
Prakash Patel and Kalpesh Shah are mutual person
- Meghdhanush Drones & Agro Technologies Private LimitedActive 8 months 7 days
Parth Parikh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 05 Feb 2024 | ₹1.40 Cr | Open |
Sidbi Creation Date: 28 Mar 2023 | ₹6.28 M | Open |
Others Creation Date: 06 Feb 2021 | ₹5.50 M | Open |
How Many Employees Work at Kesar Pharma?
Kesar Pharma has a workforce of 56 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kesar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kesar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
